TER-2013

N/A

Report date: 2025/12/04 09:39:21
NME

Base Information

Drug NameTER-2013
Drug Alias NameTER-2013
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTerremoto Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTerremoto Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsEndometrial Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A